CDKN2A and breast carcinoma: The intracellular distribution of MUC1-ARF protein, whether nuclear or/and cytoplasmic, may also be important, and extensive immunohistochemical studies will be required to see whether the quantitative and qualitative changes in MUC1-ARF expression in breast cancer tissue indeed have prognostic significance to disease outcome.